Prajit Pillai, PhD MBA

Director of Clinical Sciences, Cancer Commons

Seeking Patients with Advanced Cancer for a New Clinical Study

Cancer Commons has launched a new clinical study that features drug sensitivity testing— laboratory testing of individual patients’ cancer cells to identify drugs that might work for them. Here, our Curious Dr. George asks Cancer Commons Director of Clinical Sciences Prajit Pillai, PhD, MBA, about the study.